Delivery Order SPE2DR25D3012-SPE2DR26F4E8X
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,296.00 and a completion date of January 6, 2026. This contract utilizes a firm fixed price structure and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a $3,599.50 delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,633.36 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This contract was competitively awarded with no set-aside designation and employs firm fixed pricing. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,258.74 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract utilizes firm fixed-price pricing with a completion date of December 18, 2025, and was awarded competitively without set-aside restrictions. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,077.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (50 mg/5 g) in unit dose 5-gram packages. The contract, awarded December 31, 2025, with an ultimate completion date of January 2, 2026, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a $1,628.40 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, valued at $1,296.00 with a firm fixed price arrangement. This competitively awarded, non-set-aside contract has an ultimate completion date of June 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.70 to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with an ultimate completion date of December 24, 2025, and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract was awarded through open competition with no set-aside designation, reflecting the contractor's established...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages, valued at $1,301.87, with an ultimate completion date of November 18, 2025. This competitively awarded, non-set-aside contract is a firm fixed price delivery order, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The award was executed on November 17, 2025. This delivery order is issued under...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4E8XDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,828.25 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packages of 5 grams. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by January 13, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen). This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio with the DLA demonstrates its critical role as a major pharmaceutical distributor for the federal government, supporting military treatment facilities, the Defense Health Agency, and other federal medical institutions with essential pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/11/26 |